US · Healthcare

Rising India Inc (RBII)

Drug Manufacturers - Specialty & Generic

Rising India Inc (RBII) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for RBII

P/E ratio

18.00

Rising India Inc (RBII) — FAQ

What is RBII's P/E ratio?

The price-to-earnings (P/E) ratio for Rising India Inc (RBII) is 18.00 (data as of 2026-03-25).

Does Rising India Inc pay a dividend?

Dividend yield is not available in the current snapshot for Rising India Inc (RBII). Check the MyAverix Finance app for the latest dividend data.

What sector is Rising India Inc in?

Rising India Inc (RBII) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is RBII listed on?

RBII is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)